Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2007

View Archived Issues

Fx-1006A to be tested in phase II/III study for familial amyloid polyneuropathy

Phase III study of Multikine in head and neck cancer cleared to begin

GP-Pharm receives U.S. orphan drug status for Sarcodoxome

Novavax and collaborators enhance VLP vaccine for HIV/AIDS

Enrollment completed in phase IIb study of TRU-015 in rheumatoid arthritis

Bionomics plans IND for vascular disruption agent BNC-105

Vismed begins phase III study in dry eye syndrome

Swiss clearance for phase II anemia study of NE-180 in cancer patients

Antiinflammatory drug salsalate studied for type 2 diabetes

GenVec and NMRC begin first clinical study of malaria vaccine

Insert Therapeutics to collaborate on tubulysin conjugates

Treatment completed in acute portion of pivotal HAE study of C1-INH

Cipher's response to CIP-Isotretinoin approvable letter accepted for review

European Commission approves Tandemact

Recent patents disclose novel metabolic drugs

Recent patents describe new therapeutic agents for depression, anxiety, psychosis et al.

MN-001 shows no statistically significant improvement in interstitial cystitis

Exforge approved by European Commission for hypertension

Clinical trial will evaluate the effects of betahistine on body weight

Novel therapeutic agents for neurological disorders reported in recent patent literature

Japanese approval sought for Actos with biguanides

GPAT suggested as a new target for obesity treatment

Stress-induced phytoalexins from soy bean showed antitumor activity in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.